Thursday, June 1, 2023 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

Hemispherx Biopharma inflated its share price through false and misleading statements, shareholders claim in Philadelphia Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading...